Genotoxic Impurities and Drug Quality: Lessons from the Nitrosamine Contamination Crisis

Genotoxic Impurities and Drug Quality: Lessons from the Nitrosamine Contamination Crisis

07/16/2020, 1:15 PM - 3:00 PM

Innovation Stage, Booth 1281, Exhibit Hall
Language:
English
The discovery of genotoxic contaminants in commonly used prescription and OTC medicines over the past two years triggered expensive recalls and raised important questions about the safety of drug ingredients, testing procedures, and the supply chain for tracking materials and finished drug products. Public health questions remain unanswered. Speakers share best practices for identifying impurities and experiences with testing, and discuss the roles and responsibilities of ingredients suppliers, drug manufacturers, and regulatory authorities.

Contributors

  • Agnes Shanley

    Moderator

    Senior Editor

    Pharmaceutical Technology and BioPharm International

  • David Light

    Speaker

    CEO

    Valisure

    David Light, Founder and CEO of Valisure, is a biotech entrepreneur and scientist with over 10 years of broad experience in the field. A graduate of...

Type of Session

  1. Type of Session
    Session

Categories

  1. Track
    Keynote Series